Trial Profile
Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Jun 2015
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Doxorubicin (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 11 Dec 2011 Planned number of patients 100 added as reported by ClinicalTrials.gov.
- 11 Dec 2011 Planned End Date 1 Sep 2013 added as reported by ClinicalTrials.gov.
- 09 Oct 2007 New trial record.